FindTrial
Sign In

study of causes of hyperlipidemia and correlation with obesity

A case control study of etiological factors of medoroga w.s.r. to hyperlipidaemia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/04/042125
Enrollment
400
Registered
2022-04-25
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases

Interventions

None listed

Sponsors

DYPatil college of ayurved and research centrepune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Group A New diagnosed patients total cholesterol -above-200mg/dl s.triglycride-above-160mg/dl BMI-Above25 Group B New diagnosed patients total cholesterol -below-200mg/dl s.triglycride-below-160mg/dl BMI-below25

Exclusion criteria

Exclusion criteria: AGE-more than 60 year less than 30 year Any major illness like maglignancy,serious cardiac problem like IHD,MI,Hypothyroididsm,pregnancy,HIV,Autoimmune disease and uncontrolled DM Drug induced hyperlipidaemia .eg Glucocorticoid ,diuretics.

Design outcomes

Primary

MeasureTime frame
To study the etiological factors of Medoroga and etiological factors of hyperlipidemia. Timepoint: OBSEVATINAL-4 WEEKs—

Secondary

MeasureTime frame
To find of the association in between medoroga and hyperlipidemia based on the etiological factors and signs and symptoms Timepoint: OBSERVATIONAL-4 WEEKS—

Countries

India

Contacts

Public ContactDrPrasad navanath Ghnawat

D.Y.Patil of Ayurved and Research center ,Pimpari chinchwad Pune

maneprakash1171@gmail.com9423277615

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026